secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001104659-25-071716
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA shareholders approve asset sale to Gilead and company dissolution
-------------------------------------------------------------------------

- Asset sale to Gilead Sciences approved: 5,063,462 for, 239,595 against, 1,502 abstain.
- Plan of liquidation and dissolution approved: 4,969,875 for, 329,803 against, 4,881 abstain.
- Adjournment proposal approved: 5,110,153 for, 191,383 against, 3,023 abstain.
- Special meeting held July 29, 2025; 54.13% of outstanding shares voted.
- Company will proceed with dissolution following asset sale closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925071716/0001104659-25-071716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465925071716/tm2521991d7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-071716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer